Giacomin Jon L 4

What Happened Jon L. Giacomin, a director of Organogenesis Holdings, was granted 48,828 restricted stock units (RSUs) on February 18, 2026. The RSUs were awarded with an acquisition price of $0.00 (total recorded value $0) and each RSU represents the contingent right to one share of Class A common stock upon vesting. These RSUs vest in full on February 15, 2027. This is a compensation award (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-02-18; filing date: 2026-02-20.
• Award: 48,828 RSUs granted at $0.00 per unit (total $0 recorded).
• Vesting: RSUs vest in full on February 15, 2027 (see footnote).
• Shares owned after transaction: not specified in the provided filing.
• Filing timeliness: filing covers the 2/18/2026 grant and was submitted 2/20/2026 (no late-filing flag provided).

Context

• RSU awards are common forms of executive/director compensation and reflect future equity eligibility rather than an immediate cash purchase or sale. They typically vest over time (here, vesting in full on a fixed future date).
• Because this is a grant rather than a purchase, it should be interpreted as compensation, not necessarily a direct signal of insider buying or selling.